218 related articles for article (PubMed ID: 28580827)
41. Current Management of Acute Pulmonary Embolism.
Martinez Licha CR; McCurdy CM; Maldonado SM; Lee LS
Ann Thorac Cardiovasc Surg; 2020 Apr; 26(2):65-71. PubMed ID: 31588070
[TBL] [Abstract][Full Text] [Related]
42. Case Fatality Rates of Recurrent Thromboembolism and Bleeding in Patients Receiving Direct Oral Anticoagulants for the Initial and Extended Treatment of Venous Thromboembolism: A Systematic Review.
Gómez-Outes A; Lecumberri R; Suárez-Gea ML; Terleira-Fernández AI; Monreal M; Vargas-Castrillón E
J Cardiovasc Pharmacol Ther; 2015 Sep; 20(5):490-500. PubMed ID: 25802423
[TBL] [Abstract][Full Text] [Related]
43. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention.
Wu C; Alotaibi GS; Alsaleh K; Linkins LA; McMurtry MS
Thromb Res; 2015 Feb; 135(2):243-8. PubMed ID: 25488466
[TBL] [Abstract][Full Text] [Related]
44. Pulmonary embolism risk stratification by European Society of Cardiology is associated with recurrent venous thromboembolism: Findings from a long-term follow-up study.
Zhang S; Zhai Z; Yang Y; Zhu J; Kuang T; Xie W; Yang S; Liu F; Gong J; Shen YH; Wang C
Int J Cardiol; 2016 Jan; 202():275-81. PubMed ID: 26408837
[TBL] [Abstract][Full Text] [Related]
45. Case fatality of bleeding and recurrent venous thromboembolism during, initial therapy with direct oral anticoagulants: a systematic review.
Wu C; Alotaibi GS; Alsaleh K; Sean McMurtry M
Thromb Res; 2014 Sep; 134(3):627-32. PubMed ID: 25047174
[TBL] [Abstract][Full Text] [Related]
46. Outpatient management of stable acute pulmonary embolism: proposed accelerated pathway for risk stratification.
Almahameed A; Carman TL
Am J Med; 2007 Oct; 120(10 Suppl 2):S18-25. PubMed ID: 17916455
[TBL] [Abstract][Full Text] [Related]
47. Short-term clinical outcome after acute symptomatic pulmonary embolism.
Conget F; Otero R; Jiménez D; Martí D; Escobar C; Rodríguez C; Uresandi F; Cabezudo MA; Nauffal D; Oribe M; Yusen R
Thromb Haemost; 2008 Nov; 100(5):937-42. PubMed ID: 18989541
[TBL] [Abstract][Full Text] [Related]
48. Utilization of catheter-directed thrombolysis in pulmonary embolism and outcome difference between systemic thrombolysis and catheter-directed thrombolysis.
Patel N; Patel NJ; Agnihotri K; Panaich SS; Thakkar B; Patel A; Savani C; Patel N; Arora S; Deshmukh A; Bhatt P; Alfonso C; Cohen M; Tafur A; Elder M; Mohamed T; Attaran R; Schreiber T; Grines C; Badheka AO
Catheter Cardiovasc Interv; 2015 Dec; 86(7):1219-27. PubMed ID: 26308961
[TBL] [Abstract][Full Text] [Related]
49. Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry.
Gussoni G; Frasson S; La Regina M; Di Micco P; Monreal M;
Thromb Res; 2013 Jan; 131(1):24-30. PubMed ID: 23141849
[TBL] [Abstract][Full Text] [Related]
50. New anticoagulants in the management of venous thromboembolism in women.
Piovella F; Irina Iosub D
Thromb Res; 2015 Feb; 135 Suppl 1():S5-7. PubMed ID: 25903537
[TBL] [Abstract][Full Text] [Related]
51. Optimizing anticoagulant therapy in the management of pulmonary embolism.
Goldhaber SZ
Semin Thromb Hemost; 1999; 25 Suppl 3():129-33. PubMed ID: 10549728
[TBL] [Abstract][Full Text] [Related]
52. Non-vitamin K oral anticoagulants in patients with pulmonary embolism: a systematic review and meta-analysis of the literature.
Dentali F; Di Minno MN; Gianni M; Ambrosino P; Squizzato A; Ageno W
Intern Emerg Med; 2015 Jun; 10(4):507-14. PubMed ID: 25982918
[TBL] [Abstract][Full Text] [Related]
53. Outpatient treatment and early discharge of symptomatic pulmonary embolism: a systematic review.
Squizzato A; Galli M; Dentali F; Ageno W
Eur Respir J; 2009 May; 33(5):1148-55. PubMed ID: 19407049
[TBL] [Abstract][Full Text] [Related]
54. Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
Marik PE; Cavallazzi R
PLoS One; 2015; 10(11):e0143252. PubMed ID: 26587983
[TBL] [Abstract][Full Text] [Related]
55. Treatment of pulmonary embolism with rivaroxaban: outcomes by simplified Pulmonary Embolism Severity Index score from a post hoc analysis of the EINSTEIN PE study.
Fermann GJ; Erkens PM; Prins MH; Wells PS; Pap ÁF; Lensing AW
Acad Emerg Med; 2015 Mar; 22(3):299-307. PubMed ID: 25716463
[TBL] [Abstract][Full Text] [Related]
56. Treating pulmonary embolism in Pacific Asia with direct oral anticoagulants.
Cohen A; Jeyaindran S; Kim JY; Park K; Sompradeekul S; Tambunan KL; Tran H; Tsai IC; Ward C; Wong R
Thromb Res; 2015 Aug; 136(2):196-207. PubMed ID: 26139085
[TBL] [Abstract][Full Text] [Related]
57. Fibrinolytic and Anticoagulation Therapy in Patients Undergoing Ultrasound-Assisted Catheter-Directed Thrombolysis for Pulmonary Embolism.
Terry KJ; Buckley LF; Aldemerdash A; Fanikos J; Dell'Orfano H
Cardiovasc Hematol Disord Drug Targets; 2017; 17(2):132-135. PubMed ID: 28891451
[TBL] [Abstract][Full Text] [Related]
58. Advances in the diagnosis and management of acute pulmonary embolism.
den Exter PL; van der Hulle T; Klok FA; Huisman MV
Thromb Res; 2014 May; 133 Suppl 2():S10-6. PubMed ID: 24862127
[TBL] [Abstract][Full Text] [Related]
59. Developments in the management and treatment of pulmonary embolism.
Limbrey R; Howard L
Eur Respir Rev; 2015 Sep; 24(137):484-97. PubMed ID: 26324810
[TBL] [Abstract][Full Text] [Related]
60. [Management of pulmonary embolism: A 2015 update].
Galanaud JP; Blanchet-Deverly A; Pernod G; Quéré I;
J Mal Vasc; 2016 Feb; 41(1):51-62. PubMed ID: 26283060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
